SE8701662L - Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna - Google Patents

Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna

Info

Publication number
SE8701662L
SE8701662L SE8701662A SE8701662A SE8701662L SE 8701662 L SE8701662 L SE 8701662L SE 8701662 A SE8701662 A SE 8701662A SE 8701662 A SE8701662 A SE 8701662A SE 8701662 L SE8701662 L SE 8701662L
Authority
SE
Sweden
Prior art keywords
cells
neurological diseases
treating neurological
migraen
nerv
Prior art date
Application number
SE8701662A
Other languages
English (en)
Other versions
SE8701662D0 (sv
Inventor
A Hamberger
Original Assignee
Gelder Nico M Van
Hamberger Anders
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelder Nico M Van, Hamberger Anders filed Critical Gelder Nico M Van
Priority to SE8701662A priority Critical patent/SE8701662L/sv
Publication of SE8701662D0 publication Critical patent/SE8701662D0/sv
Priority to EP88850137A priority patent/EP0288447A1/en
Priority to DE198888850137T priority patent/DE288447T1/de
Priority to JP63096948A priority patent/JPS63313726A/ja
Priority to FI881876A priority patent/FI881876L/fi
Priority to AU15057/88A priority patent/AU606413B2/en
Priority to DK217188A priority patent/DK217188A/da
Priority to US07/184,341 priority patent/US4962121A/en
Publication of SE8701662L publication Critical patent/SE8701662L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8701662A 1987-04-22 1987-04-22 Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna SE8701662L (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8701662A SE8701662L (sv) 1987-04-22 1987-04-22 Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna
EP88850137A EP0288447A1 (en) 1987-04-22 1988-04-20 Composition for the treatment of migraine, by influencing thenerve cells.
DE198888850137T DE288447T1 (de) 1987-04-22 1988-04-20 Ein verfahren und eine zusammensetzung fuer die behandlung neurologischer krankheiten wie migraene, durch beeinflussung der nervenzellen.
JP63096948A JPS63313726A (ja) 1987-04-22 1988-04-21 神経細胞に影響を与えることにより偏頭痛のような神経性疾患を処理する方法および組成物
FI881876A FI881876L (fi) 1987-04-22 1988-04-21 Foerfarande foer framstaellning av en komposition foer anvaendning vid behandling av neurologiska sjukdomar.
AU15057/88A AU606413B2 (en) 1987-04-22 1988-04-21 A method and a composition for treating neurological diseases such as migraine, by influencing the nerve cells
DK217188A DK217188A (da) 1987-04-22 1988-04-21 Farmaceutisk praeparat til behandling af neurologiske sygdomme
US07/184,341 US4962121A (en) 1987-04-22 1988-04-21 Method and composition for treating neurological diseases such as migraine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701662A SE8701662L (sv) 1987-04-22 1987-04-22 Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna

Publications (2)

Publication Number Publication Date
SE8701662D0 SE8701662D0 (sv) 1987-04-22
SE8701662L true SE8701662L (sv) 1988-10-23

Family

ID=20368273

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701662A SE8701662L (sv) 1987-04-22 1987-04-22 Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna

Country Status (8)

Country Link
US (1) US4962121A (sv)
EP (1) EP0288447A1 (sv)
JP (1) JPS63313726A (sv)
AU (1) AU606413B2 (sv)
DE (1) DE288447T1 (sv)
DK (1) DK217188A (sv)
FI (1) FI881876L (sv)
SE (1) SE8701662L (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643954A (en) * 1992-01-10 1997-07-01 Komissarova; Irina Alexeevna Method of preventing and alleviating stress in a healthy mammal in need thereof
US6775531B1 (en) * 1994-07-21 2004-08-10 Interdigital Technology Corporation Subscriber terminal temperature regulation
US6099869A (en) * 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
WO1998039018A1 (fr) * 1997-03-03 1998-09-11 Laboratoires Remilea Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
IT1291126B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
AT407991B (de) * 1998-11-10 2001-07-25 Red Bull Gmbh Mittel zum beeinflussen des transportes von substanzen aus pro- und eukariotischen zellen oder in solche zellen
ATE298205T1 (de) * 1999-01-29 2005-07-15 Sportmedizin Team Vertriebs Gm Zusammensetzung zur leistungsförderung bei sportlicher tätigkeit, ihre herstellung und verwendung als diätetisches lebensmittel
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
AU5840200A (en) * 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
EP1872797A3 (en) 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
EP1268498B1 (en) 2000-02-29 2005-04-13 Medicure International Inc. Cardioprotective phosphonates
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
DE60128912T9 (de) 2000-07-07 2008-06-26 Medicure International Inc. Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6465517B1 (en) * 2000-07-11 2002-10-15 N.V. Nutricia Composition for the treatment of migraine
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
GB0207830D0 (en) * 2002-04-04 2002-05-15 Mars Uk Ltd Animal composition
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
EP1773370A1 (en) * 2004-07-07 2007-04-18 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006050598A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2826019C (en) * 2011-01-26 2017-08-01 Nico Worldwide Inc. Remedy for migraine headache
JP6265908B2 (ja) 2011-11-21 2018-01-24 ザ インスティチュート フォー エスノメディシン 神経変性疾患および障害を処置するためのｌ−セリン組成物、方法および使用
DE102012110009A1 (de) * 2012-10-19 2014-04-24 Thomas Gniech Mittel zur Linderung oder gegen Migräneschmerzen
GB201709459D0 (en) * 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3189M (fr) * 1963-07-13 1965-03-15 Pharmaco Biolog Soc Médicament a base d'acide 2-amino-éthanesulfonique.
FR5955M (sv) * 1966-11-08 1968-04-16
DE2502735B2 (de) * 1975-01-23 1978-11-23 J. Pfrimmer & Co, 8520 Erlangen Verwendung von Glycerophosphaten
US4303692A (en) * 1978-11-22 1981-12-01 Gaull Gerald E Infant milk formula
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
US4439452A (en) * 1979-02-14 1984-03-27 Seymour Enrenpreis Class of analgesics and/or anti-inflammatory agents consisting of inhibitors of breakdown of endogenous enkephalin and/or endorphin, and combinations of said analgesics with antipyretic, anti-inflammatory (aspirin-type) drugs
DE2921852A1 (de) * 1979-05-29 1980-12-11 Fresenius Chem Pharm Ind Lipide senkendes mittel
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
IE55320B1 (en) * 1983-06-16 1990-08-01 Farley Health Products Infant foods
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4629625A (en) * 1984-08-29 1986-12-16 Gaull Gerald E Human nutritional compositions containing taurine and vitamins and/or minerals
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training

Also Published As

Publication number Publication date
DE288447T1 (de) 1989-02-16
FI881876A7 (sv) 1988-10-23
EP0288447A1 (en) 1988-10-26
FI881876L (fi) 1988-10-23
AU606413B2 (en) 1991-02-07
AU1505788A (en) 1988-10-27
JPS63313726A (ja) 1988-12-21
DK217188D0 (da) 1988-04-21
FI881876A0 (fi) 1988-04-21
SE8701662D0 (sv) 1987-04-22
DK217188A (da) 1988-10-23
US4962121A (en) 1990-10-09

Similar Documents

Publication Publication Date Title
SE8701662D0 (sv) Sett och medel for att behandla neurologiska sjukdomar, exempelvis migren genom paverkan av nervcellerna
DE3176215D1 (en) Non-yellowing topical pharmaceutical composition
ES2067022T3 (es) Complejos estabilizados de oxido nitrico y aminas primarias utiles como agentes cardiovasculares.
ES8307491A1 (es) Un metodo para preparar una composicion de gel acuoso semi- solido para alimentacion de heridos
EP0203649A3 (en) Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
PT79055A (en) Novel growth hormone-releasing peptides and method of treating mammals therewith
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
DE59103442D1 (de) Therapeutisch wirksames stoffgemisch aus glutathion- und anthocyan-verbindungen.
FI871304A0 (sv) Förfarande för framställning av aminosyraderivat med notropisk verkan
DE3584250D1 (de) Mittel zum stimulieren des haarwuchses.
PH27384A (en) Hair treatment compositions
GR3029319T3 (en) Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
AU643760B2 (en) Method and composition for increased skin concentration of active agents by iontophoresis
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE65179T1 (de) Mittel zur behandlung von keratosis.
DE69031038D1 (de) Peptidderivate
HUT35926A (en) Compositions for treating plant diseases and process for producing substituted benzopenta-thiepine derivatives utilizable as active agents
JPS5520721A (en) Separation of biologically active material from hematopiesis tissue of domestic animal
SE8704832L (sv) Preparat foer tandbehandling jaemte foerfarande foer framstaellning av preparatet
SU1823184A1 (ru) Способ получения вещества, обладающего антипротеазным действием
GB2126597B (en) Compositions for treating dental pulpitis
HUT40916A (en) Process for producing compositions for promoting healing of the wounds
DE3867569D1 (de) Collagen und imidazol-derivate enthaltende therapeutische zusammensetzungen.
AU4288285A (en) Novel pharmaceutical compositions having immuno-suppressive properties

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701662-2

Effective date: 19920406

Format of ref document f/p: F